Tobacco Products Scientific Advisory Committee; Amendment of Notice, 10609 [2011-4191]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 38 / Friday, February 25, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2006–N–0237] (formerly
2006N–0061)
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Charging for Investigational Drugs
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Charging for Investigational Drugs’’ has
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Berbakos, Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, 301–
796–3792,
Elizabeth.Berbakos@fda.hhs.gov.
SUMMARY:
In the
Federal Register of December 14, 2006
(71 FR 75168), the Agency announced
that the proposed information collection
had been submitted to OMB for review
and clearance under 44 U.S.C. 3507. An
Agency may not conduct or sponsor,
and a person is not required to respond
to, a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0651. The
approval expires on December 31, 2011.
A copy of the supporting statement for
this information collection is available
on the Internet at https://
www.reginfo.gov/public/do/PRAMain.
SUPPLEMENTARY INFORMATION:
Dated: February 18, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–4217 Filed 2–24–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
srobinson on DSKHWCL6B1PROD with NOTICES
Food and Drug Administration
[Docket No. FDA–2011–N–0002]
Tobacco Products Scientific Advisory
Committee; Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
VerDate Mar<15>2010
16:39 Feb 24, 2011
Jkt 223001
The Food and Drug Administration
(FDA) is announcing an amendment to
the notice of a meeting of the Tobacco
Products Scientific Advisory
Committee. This meeting was
announced in the Federal Register of
January 26, 2011 (76 FR 4705). The
amendment is being made to reflect a
change in the Date and Time, Agenda,
Procedures, and Closed Committee
Deliberations portions of the document.
There are no other changes.
FOR FURTHER INFORMATION CONTACT:
Caryn Cohen, Office of Science, Center
for Tobacco Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD, 20850, 1–877–287–1373
(choose option 4), e-mail:
TPSAC@fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area), and follow the
prompts to the desired center or product
area. Please call the Information Line for
up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In the
Federal Register of January 26, 2011,
FDA announced that a meeting of the
Tobacco Products Scientific Advisory
Committee would be held on March 1
and 2, 2011. On page 4075, in the third
column, the Date and Time portion of
the document is changed to read as
follows:
Date and Time: The meeting will be
held on March 2, 2011, from 8 a.m. to
5 p.m.
On page 4076, in the first column, the
Agenda portion is changed to read as
follows:
Agenda: On March 2, 2011, the
Committee will continue to: (1) Receive
updates from the Menthol Report
Subcommittee and (2) receive and
discuss presentations regarding the data
requested by the Committee at the
March 30 and 31, 2010, meeting of the
Tobacco Products Advisory Committee.
On page 4076, in the first column, the
Procedure portion is changed to read as
follows:
Procedure: On March 2, 2011, from
10:30 a.m. to 5 p.m., the meeting is open
to the public. Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before February 15, 2011.
Oral presentations from the public will
be scheduled between approximately 2
p.m. and 3 p.m. on March 2, 2011.
Those individuals interested in making
formal oral presentations should notify
the contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
10609
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before February 8, 2011. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
February 9, 2011.
On page 4076, in the second column,
the Closed Committee Deliberations
portion is changed to read as follows:
Closed Committee Deliberations: On
March 2, 2011, from 8 a.m. to 10 a.m.,
the meeting will be closed to permit
discussion and review of trade secret
and/or confidential commercial
information (5 U.S.C. 552b(c)(4)). This
portion of the meeting must be closed
because the Committee will be
discussing confidential data provided
by the Federal Trade Commission (FTC)
and the tobacco industry.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
Dated: February 18, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2011–4191 Filed 2–24–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Form I–290B, Revision of an
Existing Information Collection;
Comment Request
30-Day Notice of Information
Collection Under Review: Form I–290B,
Notice of Appeal to the Office of
Administrative Appeals (AAO); OMB
Control No. 1615–0095.
ACTION:
The Department of Homeland
Security, U.S. Citizenship and
Immigration Services (USCIS) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection was
previously published in the Federal
Register on November 16, 2010, at 75
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 76, Number 38 (Friday, February 25, 2011)]
[Notices]
[Page 10609]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4191]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0002]
Tobacco Products Scientific Advisory Committee; Amendment of
Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing an amendment
to the notice of a meeting of the Tobacco Products Scientific Advisory
Committee. This meeting was announced in the Federal Register of
January 26, 2011 (76 FR 4705). The amendment is being made to reflect a
change in the Date and Time, Agenda, Procedures, and Closed Committee
Deliberations portions of the document. There are no other changes.
FOR FURTHER INFORMATION CONTACT: Caryn Cohen, Office of Science, Center
for Tobacco Products, Food and Drug Administration, 9200 Corporate
Blvd., Rockville, MD, 20850, 1-877-287-1373 (choose option 4), e-mail:
TPSAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area), and follow the
prompts to the desired center or product area. Please call the
Information Line for up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of January 26, 2011,
FDA announced that a meeting of the Tobacco Products Scientific
Advisory Committee would be held on March 1 and 2, 2011. On page 4075,
in the third column, the Date and Time portion of the document is
changed to read as follows:
Date and Time: The meeting will be held on March 2, 2011, from 8
a.m. to 5 p.m.
On page 4076, in the first column, the Agenda portion is changed to
read as follows:
Agenda: On March 2, 2011, the Committee will continue to: (1)
Receive updates from the Menthol Report Subcommittee and (2) receive
and discuss presentations regarding the data requested by the Committee
at the March 30 and 31, 2010, meeting of the Tobacco Products Advisory
Committee.
On page 4076, in the first column, the Procedure portion is changed
to read as follows:
Procedure: On March 2, 2011, from 10:30 a.m. to 5 p.m., the meeting
is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committee. Written submissions may be made to the contact person on
or before February 15, 2011. Oral presentations from the public will be
scheduled between approximately 2 p.m. and 3 p.m. on March 2, 2011.
Those individuals interested in making formal oral presentations should
notify the contact person and submit a brief statement of the general
nature of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
February 8, 2011. Time allotted for each presentation may be limited.
If the number of registrants requesting to speak is greater than can be
reasonably accommodated during the scheduled open public hearing
session, FDA may conduct a lottery to determine the speakers for the
scheduled open public hearing session. The contact person will notify
interested persons regarding their request to speak by February 9,
2011.
On page 4076, in the second column, the Closed Committee
Deliberations portion is changed to read as follows:
Closed Committee Deliberations: On March 2, 2011, from 8 a.m. to 10
a.m., the meeting will be closed to permit discussion and review of
trade secret and/or confidential commercial information (5 U.S.C.
552b(c)(4)). This portion of the meeting must be closed because the
Committee will be discussing confidential data provided by the Federal
Trade Commission (FTC) and the tobacco industry.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: February 18, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2011-4191 Filed 2-24-11; 8:45 am]
BILLING CODE 4160-01-P
